Melatonin and Adiponectin in Hypertensive Kidney Transplant
Completed
- Conditions
- HypertensionKidney Transplant
- Registration Number
- NCT00498576
- Lead Sponsor
- Sheba Medical Center
- Brief Summary
Recently we have shown that melatonin secretion is impaired in rats with metabolic syndrome. We have also demonstrated that exogenic melatonin supplementation can improve blood pressure profile in nondipper patients.
The aim of this study is to find whether there is a difference between melatonin secretion in hypertensive kidney recipients versus "normal" hypertensive patients. Secondly, to ask if there is any correlation between melatonin secretion and adiponectin levels.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- hypertension
- kidney transplantation ( group 1)
- good renal function
Exclusion Criteria
- diabetes mellitus
- cancer
- renal failure
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sheba Medical Center
🇮🇱Ramat-gan, Israel